Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • Pfizer (Australia) TOBRAMYCIN (as sulfate) 80 mg/2 mL

    Availability: Unavailable Deletion from market: 01 Oct 2024
  • BETASERT betahistine dihydrochloride 16 mg

    Availability: Unavailable Deletion from market: 06 Aug 2024
  • TEVETEN eprosartan 400mg

    Availability: Unavailable Deletion from market: 07 Aug 2024
  • APO-BETAHISTINE betahistine dihydrochloride 16 mg

    Availability: Unavailable Deletion from market: 06 Aug 2024
  • ROXIMYCIN roxithromycin 150mg

    Availability: Unavailable Deletion from market: 05 Aug 2024
  • ROXIMYCIN roxithromycin 300mg

    Availability: Unavailable Deletion from market: 05 Aug 2024
  • KETORAL ketorolac trometamol 30mg/1mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 28 Oct 2024
    View Detail
  • CEPTOLATE mycophenolate mofetil 250mg

    Availability: Unavailable Deletion from market: 02 Aug 2024
  • EPHEDRINE HYDROCHLORIDE JUNO ephedrine hydrochloride 30 mg/10 mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Sep 2024
  • COLIFOAM (10% w/w Hydrocortisone Acetate) Rectal Foam Cream aerosol can

    Availability: Unavailable Deletion from market: 02 Aug 2024
  • TEVETEN eprosartan 600mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Dec 2024
  • TRYZAN TABS 5 ramipril 5.0 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Sep 2024